Skip to main content
OpenTrials
Completed

NCT Number: NCT03108014

Beginnings Study Follow up

This study will help us learn more about how early infant diet may influence child's growth and development at age 14.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

13 year–15 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Arkansas Children's Nutrition Center

Little Rock, Arkansas, 72202, United States

About this study

This study is to follow the infants that were enrolled in Beginnings study which purpose was to characterize physical growth, body composition, dietary intake, neurobehavioral development, and brain function of infants and children fed mostly breast milk, milk based formula, or soy based formula during their first year of life up to age 6. This study will call back those children when they turn 14 to compare growth, sexual maturation, and development between the three diets.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Beginnings study former participants

Exclusion criteria

  • Dropped participants for medical diagnosis or medical conditions

Treatment and study plan

Primary outcomes

  1. Growth and development

    Time frame: 14 years

    Will be determined with body composition equipment

Sponsors and collaborators

Lead sponsor

Arkansas Children's Hospital Research Institute

Other

Registry information

Important dates

Study start
2017
Primary completion
2024
Study completion
2024
First posted
Apr 11, 2017
Registry last updated
Jan 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.